The Public Health Agency of Canada (PHAC) is collaborating with the National Collaborating Centre for Infectious Diseases (NCCID) to produce a webinar to discuss the current vaccine landscape in Canada and provide an overview of the latest recommendations from the National Advisory Committee on Immunization (NACI) for respiratory syncytial virus (RSV), seasonal influenza, and COVID-19 for the 2024-2025 respiratory virus season.
At the end of this webinar, participants will be able to
- discuss RSV, influenza, and COVID-19 in Canada;
- discuss vaccines and/or monoclonal antibodies available for these respiratory viruses; and
- identify where to access NACI guidance, Canadian influenza antiviral guidelines, and other resources relevant to the prevention and treatment of respiratory illnesses during the 2024-2025 season.
Event information
This webinar will be delivered in English. Participants will have the opportunity to ask questions via the pre-webinar registration questionnaire, throughout the live webinar using a Q&A function, and during the Q&A period after the presentations. Post event, a recording of the webinar in addition to a PDF of the slide deck will be posted on the NCCID website.
- Date: Tuesday, September 24, 2024.
- Time: 9:30 a.m. to 11:00 a.m. MT.
- Register: here.
Also, look for updates on ACP’s Seasonal immunization information webpage in the weeks leading up to the launch of Alberta’s 2024-25 Influenza Immunization Program.
